These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 25192935)

  • 1. Progressive increase in mtDNA 3243A>G heteroplasmy causes abrupt transcriptional reprogramming.
    Picard M; Zhang J; Hancock S; Derbeneva O; Golhar R; Golik P; O'Hearn S; Levy S; Potluri P; Lvova M; Davila A; Lin CS; Perin JC; Rappaport EF; Hakonarson H; Trounce IA; Procaccio V; Wallace DC
    Proc Natl Acad Sci U S A; 2014 Sep; 111(38):E4033-42. PubMed ID: 25192935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of nuclear epigenome by mitochondrial DNA heteroplasmy.
    Kopinski PK; Janssen KA; Schaefer PM; Trefely S; Perry CE; Potluri P; Tintos-Hernandez JA; Singh LN; Karch KR; Campbell SL; Doan MT; Jiang H; Nissim I; Nakamaru-Ogiso E; Wellen KE; Snyder NW; Garcia BA; Wallace DC
    Proc Natl Acad Sci U S A; 2019 Aug; 116(32):16028-16035. PubMed ID: 31253706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MELAS mutation m.3243A>G promotes reactivation of fetal cardiac genes and an epithelial-mesenchymal transition-like program via dysregulation of miRNAs.
    Meseguer S; Panadero J; Navarro-González C; Villarroya M; Boutoual R; Comi GP; Armengod ME
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3022-3037. PubMed ID: 29928977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS.
    Desquiret-Dumas V; Gueguen N; Barth M; Chevrollier A; Hancock S; Wallace DC; Amati-Bonneau P; Henrion D; Bonneau D; Reynier P; Procaccio V
    Biochim Biophys Acta; 2012 Jun; 1822(6):1019-29. PubMed ID: 22306605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementation and segregation behavior of disease-causing mitochondrial DNA mutations in cellular model systems.
    Attardi G; Yoneda M; Chomyn A
    Biochim Biophys Acta; 1995 May; 1271(1):241-8. PubMed ID: 7599215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode syndrome-associated human mitochondrial tRNALeu(UUR) mutation causes aminoacylation deficiency and concomitant reduced association of mRNA with ribosomes.
    Chomyn A; Enriquez JA; Micol V; Fernandez-Silva P; Attardi G
    J Biol Chem; 2000 Jun; 275(25):19198-209. PubMed ID: 10858457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine mapping of mitochondrial RNAs derived from the mtDNA region containing a point mutation associated with MELAS.
    Koga Y; Davidson M; Schon EA; King MP
    Nucleic Acids Res; 1993 Feb; 21(3):657-62. PubMed ID: 7680123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs.
    Yang Y; Wu H; Kang X; Liang Y; Lan T; Li T; Tan T; Peng J; Zhang Q; An G; Liu Y; Yu Q; Ma Z; Lian Y; Soh BS; Chen Q; Liu P; Chen Y; Sun X; Li R; Zhen X; Liu P; Yu Y; Li X; Fan Y
    Protein Cell; 2018 Mar; 9(3):283-297. PubMed ID: 29318513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective respiratory capacity and mitochondrial protein synthesis in transformant cybrids harboring the tRNA(Leu(UUR)) mutation associated with maternally inherited myopathy and cardiomyopathy.
    Mariotti C; Tiranti V; Carrara F; Dallapiccola B; DiDonato S; Zeviani M
    J Clin Invest; 1994 Mar; 93(3):1102-7. PubMed ID: 8132749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia.
    Munakata K; Iwamoto K; Bundo M; Kato T
    Biol Psychiatry; 2005 Mar; 57(5):525-32. PubMed ID: 15737668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic rescue in pluripotent cells from patients with mtDNA disease.
    Ma H; Folmes CD; Wu J; Morey R; Mora-Castilla S; Ocampo A; Ma L; Poulton J; Wang X; Ahmed R; Kang E; Lee Y; Hayama T; Li Y; Van Dyken C; Gutierrez NM; Tippner-Hedges R; Koski A; Mitalipov N; Amato P; Wolf DP; Huang T; Terzic A; Laurent LC; Izpisua Belmonte JC; Mitalipov S
    Nature; 2015 Aug; 524(7564):234-8. PubMed ID: 26176921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of low levels of the mitochondrial tRNALeu(UUR) 3243A>G mutation in blood derived from patients with diabetes.
    Procaccio V; Neckelmann N; Paquis-Flucklinger V; Bannwarth S; Jimenez R; Davila A; Poole JC; Wallace DC
    Mol Diagn Ther; 2006; 10(6):381-9. PubMed ID: 17154655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel heteroplasmic tRNAleu(CUN) mtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in skeletal muscle and suggests an approach to therapy.
    Fu K; Hartlen R; Johns T; Genge A; Karpati G; Shoubridge EA
    Hum Mol Genet; 1996 Nov; 5(11):1835-40. PubMed ID: 8923013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial DNA associations with East Asian metabolic syndrome.
    Chalkia D; Chang YC; Derbeneva O; Lvova M; Wang P; Mishmar D; Liu X; Singh LN; Chuang LM; Wallace DC
    Biochim Biophys Acta Bioenerg; 2018 Sep; 1859(9):878-892. PubMed ID: 29997041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and molecular mitochondrial abnormalities associated with a C --> T transition at position 3256 of the human mitochondrial genome. The effects of a pathogenic mitochondrial tRNA point mutation in organelle translation and RNA processing.
    Hao H; Moraes CT
    J Biol Chem; 1996 Jan; 271(4):2347-52. PubMed ID: 8567699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of Mitochondria DNA Mutations in Diseases.
    Zhu Z; Wang X
    Adv Exp Med Biol; 2017; 1038():219-230. PubMed ID: 29178079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Deoxy-D-glucose couples mitochondrial DNA replication with mitochondrial fitness and promotes the selection of wild-type over mutant mitochondrial DNA.
    Pantic B; Ives D; Mennuni M; Perez-Rodriguez D; Fernandez-Pelayo U; Lopez de Arbina A; Muñoz-Oreja M; Villar-Fernandez M; Dang TJ; Vergani L; Johnston IG; Pitceathly RDS; McFarland R; Hanna MG; Taylor RW; Holt IJ; Spinazzola A
    Nat Commun; 2021 Dec; 12(1):6997. PubMed ID: 34873176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient elimination of MELAS-associated m.3243G mutant mitochondrial DNA by an engineered mitoARCUS nuclease.
    Shoop WK; Lape J; Trum M; Powell A; Sevigny E; Mischler A; Bacman SR; Fontanesi F; Smith J; Jantz D; Gorsuch CL; Moraes CT
    Nat Metab; 2023 Dec; 5(12):2169-2183. PubMed ID: 38036771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis.
    Shidara Y; Yamagata K; Kanamori T; Nakano K; Kwong JQ; Manfredi G; Oda H; Ohta S
    Cancer Res; 2005 Mar; 65(5):1655-63. PubMed ID: 15753359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial DNA diseases: histological and cellular studies.
    Shoubridge EA
    J Bioenerg Biomembr; 1994 Jun; 26(3):301-10. PubMed ID: 8077183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.